Association of Advanced Leukemic Stage and Skin Cancer Tumor Stage With Poor Skin Cancer Outcomes in Patients With Chronic Lymphocytic Leukemia
Nicole F. Vélez(Brigham and Women's Hospital), Chrysalyne D. Schmults(Dana-Farber Brigham Cancer Center), Jennifer R. Brown(Dana-Farber Cancer Institute), Pritesh S. Karia(Brigham and Women's Hospital), Matthew S. Davids(Dana-Farber Cancer Institute), Alexander R. Vartanov(Harvard University)
Cited by 104
Related Papers
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|890
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
|Journal of Clinical Oncology|2017|752